Clinical Role - Payer

Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.

What should covered entities do to prepare for increased reporting requirements?
The waivers were approved within days of the states' submissions.
One of the primary means of performing billable services is through ‘incident-to’ billing.
The growth of the pipeline has led to increases in insurance carriers’ specialty plan spend.
Members of AHIP will take steps to ensure affordable access to COVID-19 testing and treatment, according to a statement from the company.
Earlier this week, the FDA updated its guidance on testing for the novel coronavirus (COVID-19), allowing clinical laboratories to create and perform COVID-19 tests without pursuing FDA emergency use authorization (EUA).
The researchers found that the average yearly out-of-pocket spending by patients with diabetes is over $1,800.
The approval allows Florida to waive certain requirements in Medicare, Medicaid, and CHIP.
The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.
The law makes New Mexico the third state to enact a co-pay cap for insulin.
Online pharmacy Valisure has found high levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in batches of metformin from 11 out of 22 tested manufacturers.1
Using the 2012 to 2017 Medicare Part D Drug Event and Medicaid Spending and Utilization data sets, the researchers analyzed 20 extended-release drugs with 37 Medicare formulations and 36 Medicaid formulations. The analyses were conducted from January to December 2019.